protein kinase inhibitors: insights drug design structure
protein kinases targets treatment number diseases review focuses kinase inhibitors clinic clinical trials structural information available structures informed drug design illuminated mechanism inhibition review progress receptor tyrosine kinases growth factor receptors egfr vegfr fgfr nonreceptor tyrosine kinases bcr-abl advances made cancer therapeutic agents herceptin gleevec among serine-threonine kinases p38 rho-kinase cyclin-dependent kinases chk1 targeted productive results inflammation cancer structures provided insights targeting inactive active form kinase targeting global constellation residues atp site less conserved additional pockets single residues targeting noncatalytic domains
